摘要
目的:提高肾嫌色细胞癌的诊治水平和对此类型肾癌的认识。方法:结合文献回顾性分析9例肾嫌色细胞癌的临床和病理资料。1996年1月～2006年12月我院共收治124例肾癌,其中肾嫌色细胞癌占9例(7.25%),9例肾嫌色细胞癌均行根治性肾切除术。结果:术后病理证实为肾嫌色细胞癌。病理分期:pT_14例,pT_22例,pT_(3b)1例,pT_1N_2M_01例,pT_2N_2M_01例。病理分级:G_2 6例,G_33例。7例获随访,随访6～24个月,平均16个月,2例死于心脏病,未见肿瘤局部复发,5例无瘤生存。结论:肾嫌色细胞癌是一种具有特殊形态的少见肾癌类型。根治性肾切除术是治疗肾嫌色细胞癌的首选方法。与同期、同级的其它类型肾癌相比较,肾嫌色细胞癌预后较好。
Objective： To evaluate the capability of diagnosis and treatment of renal chromphobe cell carcinoma （RCCC） and to improve the recognization of this subtype of renal cell carcinoma （RCC）. Methods： Nine cases of RCCC were analysed retrospectively with review of the literature. 124 cases of RCC were encountered in our institute form January 1996 to December 2006 and 9 （7. 250//oo） of them were RCCC. Radical nephretomy was performed in all cases of RCCC. Results： Pathological findings affirmed the diagnosis of RCCC after operation. The pathologic TNM stage of RCCC was pT1 in 4 cases, pT2 in 2 cases, pT3b in 1 eases,pT1N2M0 in one and pT2N2M0 in one. The pathologic grade of RCCC was G2 in 6 cases, G3 in 3 cases. 7 cases had been followed up. During the follow-up of 6 months to 24 months （mean 16 months）, two died of heart attack, 5 were enjoying tumor free lives. Conclusion： RCCC is a morphologically distinctive uncommon subtype of RCC. Radical nephretomy is the first choice for the treatment of RCCC. Compared with other type of RCC at the same stage and of the same grade, RCCC has a better prognosis.
出处
《新疆医科大学学报》
CAS
2009年第9期1276-1277,共2页
Journal of Xinjiang Medical University
关键词
肾细胞癌
嫌色细胞癌
病理学
renal cell carcinoma； chromphobe cell carcinoma
pathology
